Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

EvoMG-DN Evolutionary Medical Genomics Doctoral Network

Coordinator
Fundacio Centre De Regulacio Genomica, Spain
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€4.6m
Total cost
—
Partners
23 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226544

What the project is doing

In the project's own words, from its summary on CORDIS.

The Evolutionary Medical Genomics Doctoral Network (EvoMG-DN) pioneers an integrative approach combining Evolutionary Medicine and Medical Genomics to address critical health challenges. By combining evolutionary insights with state-of-the-art genomic tools, EvoMG-DN seeks to establish EvoMG as a structured and impactful discipline in Europe. The network aims to train the next generation of interdisciplinary researchers to unlock the full potential of evolutionary genomic approaches in healthcare.

EvoMG-DN pursues three overarching objectives: (i) foster interdisciplinary synergy by uniting EvoMG researchers from diverse fields to catalyze innovation in methodologies and tools; (ii) create a cohesive training framework, equipping doctoral candidates (DCs) with expertise in EvoMG applications through structured training and collaboration; and (iii) advance evolution-informed clinical applications, such as adaptive cancer therapies.

The research program is organized into three scientific work packages: WP1 explores evolutionary insights into ageing and age-related diseases; WP2 focuses on tumor evolution and acquisition of resistance in cancer therapies; and WP3 addresses pathogen evolution, antibiotic resistance and interactions with the immune system. These are underpinned by core methodological pillars, which include comparative functional genomics, genetic diversity analysis, mathematical modeling and machine learning, and the use of unconventional model organisms.

Through interdisciplinary secondments, tailored mentoring, and advanced training modules, EvoMG-DN empowers DCs to bridge disciplines and develop actionable solutions to global health challenges. By formalizing EvoMG methodologies and advancing clinical applications, EvoMG-DN aims to solidify Europe’s leadership in biomedical research and deliver long-lasting societal impact.

Topics

Who is involved

OrganisationCityCountryRole
Fundacio Centre De Regulacio GenomicaBarcelonaSpainCoordinator
European Molecular Biology OrganizationGeneveSwitzerlandAssociatedpartner
Friedrich-Schiller-Universität JenaJenaGermanyAssociatedpartner
Leibniz-Institut Fur Alternsforschung - Fritz-Lipmann-Institut eV (fli) Leibniz Institute on Aging - Fritz Lipmann Institute eV (fli)JenaGermanyParticipant
Barcelona Supercomputing Center Centro Nacional De SupercomputacionBarcelonaSpainParticipant
Fundacio D'estudis I Recerca Oncologica (fero)BarcelonaSpainAssociatedpartner
Microomics Systems S.L.BarcelonaSpainAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainParticipant
Universitat De BarcelonaBarcelonaSpainAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Ecole Normale SuperieureParisFranceAssociatedpartner
Institut PasteurParisFranceParticipant
Universite Paris CiteParisFranceAssociatedpartner
University College Dublin, National University of Ireland, DublinDublinIrelandParticipant
Faculdade De Medicina Da Universidade De LisboaLisboaPortugalAssociatedpartner
Fundacao Gimm - Gulbenkian Institute for Molecular MedicineLisboaPortugalParticipant
Universidade Nova De LisboaLisboaPortugalParticipant
Chalmers Tekniska Hogskola AktiebolagGoteborgSwedenParticipant
Institute of Cancer Research: the Royal Cancer Hospital LbgLondonUnited KingdomParticipant
Mashauri LimitedAddlestoneUnited KingdomAssociatedpartner
Nonacus LtdWalsallUnited KingdomAssociatedpartner
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomParticipant
Duke UniversityDurham NcUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI